| Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases DP Anthony, M Hegde, SS Shetty, T Rafic, S Mutalik, BSS Rao Life sciences 274, 119326, 2021 | 87 | 2021 |
| In Vitro Studies of the Antimicrobial and Free-Radical Scavenging Potentials of Silver Nanoparticles Biosynthesized From the Extract of Desmostachya bipinnata SR Guntur, NSS Kumar, MM Hegde, VR Dirisala Analytical chemistry insights 13, 1177390118782877, 2018 | 73 | 2018 |
| Biomimetic nanoarchitecturing: A disguised attack on cancer cells A Jha, AN Nikam, S Kulkarni, SP Mutalik, A Pandey, M Hegde, BSS Rao, ... Journal of controlled release 329, 413-433, 2021 | 41 | 2021 |
| Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches MM Hegde, S Prabhu, S Mutalik, A Chatterjee, JS Goda, BS Satish Rao Journal of Pharmaceutical Investigation, 1-26, 2022 | 39 | 2022 |
| Cavitation erosion and corrosion resistance of hydrophobic sol-gel coatings on aluminium alloy M Hegde, J Mohan, MQM Warraich, Y Kavanagh, B Duffy, EF Tobin Wear 524, 204766, 2023 | 20 | 2023 |
| Development of Lipidic Nanoplatform for Intra-Oral Delivery of Chlorhexidine: Characterization, Biocompatibility, and Assessment of Depth of Penetration in Extracted Human Teeth KS Shirur, BS Padya, A Pandey, MM Hegde, AI Narayan, BSS Rao, ... Nanomaterials 12 (19), 3372, 2022 | 9 | 2022 |
| Multifunctional hybrid sol-gel coatings for marine renewable energy applications: synthesis, characterization and comparative analysis with organically modified silicon … M Hegde, Y Kavanagh, B Duffy, EF Tobin MRS Advances 5 (33-34), 1757-1764, 2020 | 7 | 2020 |
| Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects MM Hegde, P Sandbhor, V Gota, JS Goda Frontiers in Oncology 13, 1168454, 2023 | 6 | 2023 |
| Abrasion and cavitation erosion resistance of multi-layer dip coated sol-gel coatings on AA2024-T3 M Hegde, Y Kavanagh, B Duffy, EF Tobin Corrosion and Materials Degradation 3 (4), 661-671, 2022 | 6 | 2022 |
| Affinity membranes for capture of cells and biological substances R Saranya, R Murugan, M Hegde, J Doyle, R Babu Filtering media by electrospinning: next generation membranes for separation …, 2018 | 4 | 2018 |
| The effect of curing on the properties of 3-methacryloxypropyltrimethoxysilane based sol-gel coatings developed for protective applications in water-based environments M Hegde, MQM Warraich, W Bashir, Y Kavanagh, B Duffy, EF Tobin Surface and Coatings Technology 479, 130442, 2024 | 3 | 2024 |
| Preliminary Evaluation of functional coatings for marine based renewable energy applications M Hegde, Y Kavanagh, B Duffy, EF Tobin Proceedings of the 13th International Conference on Damage Assessment of …, 2019 | 2 | 2019 |
| Valorisation of Tomato Waste as a Source of Cutin for Hydrophobic Surface Coatings to Protect Starch-and Gelatine-Blend Bioplastics M Mroczkowska, D Culliton, KJ Germaine, M Hegde, EF Tobin, AC Neves Biomass 4 (3), 990-1004, 2024 | 1 | 2024 |
| Influence of physical and mechanical parameters on cavitation erosion and antifouling behaviour of multilayer silica-based hybrid sol–gel coatings on aluminium alloys M Hegde, M Mroczkowska, J Mohan, AC Neves, Y Kavanagh, B Duffy, ... Eng 4 (2), 1393-1408, 2023 | 1 | 2023 |
| Enhancing glioblastoma cytotoxicity through encapsulating O6-benzylguanine and temozolomide in PEGylated liposomal nanocarrier: an in vitro study MM Hegde, P Palkar, SP Mutalik, S Mutalik, JS Goda, BS Rao 3 Biotech 14 (11), 1-19, 2024 | | 2024 |
| Engineering Multifunctional Lipid Nanocomplexes for Precision Glioblastoma Therapy: A Paradigm Shift in Treatment Strategies MM Hegde, P Palkar, JS Goda, S Mutalik, S Rao | | 2024 |
| Development of Lipidic Nanoplatform for Intra-Oral Delivery of Chlorhexidine: Characterization, Biocompatibility, and Assessment of Depth of Penetration in Extracted Human … KS Shirur, BS Padya, A Pandey, MM Hegde, AI Narayan, BSS Rao, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| A phase I study of temozolomide (Temodar (R)) in pediatric patients with relapsed or refractory leukemia-A children's oncology group study. TM Horton, E Dolan, M Hegde, SL Berg, P Adamson, SM Blaney BLOOD 106 (11), 192B-192B, 2005 | | 2005 |
